60至75岁患者保留瓣膜与生物Bentall主动脉根部置换的疗效比较
多中心回顾性研究纳入2002至2022年299例60-75岁主动脉根部手术患者,82例(27.4%)行保留瓣膜根部置换(VSRR),217例(72.6%)行生物Bentall。
要点
- VSRR与生物Bentall在60-75岁患者中院内死亡率低且远期生存良好。
- VSRR组远期心脏生存率更高,感染性心内膜炎、永久起搏器植入和心衰发作更少。
- 两组再干预或至少中度主动脉瓣反流复发率无显著差异。
核心结论
- 在60-75岁患者中,VSRR与生物Bentall均具有低院内死亡率和良好远期生存。
- VSRR与更高的远期心脏生存率相关,感染性心内膜炎、永久起搏器植入和心衰发作率更低。
- 两组再干预或至少中度主动脉瓣反流复发率相似。
研究设计与样本
- 多中心回顾性研究,2002至2022年纳入299例60-75岁行主动脉根部手术的患者。
- 82例(27.4%)行VSRR(David技术),217例(72.6%)行生物Bentall。
- 采用逆概率治疗加权(IPTW)平衡临床变量,中位随访15年(IQR 12-18年)。
主要发现
- 基线特征无重大差异;ARR组二叶瓣(4.9% vs 19%)、重度AR(42% vs 51%)、A型主动脉夹层(1.2% vs 6.9%)和再次手术(4% vs 23%)比例更高。
临床怎么用
- 对于60-75岁主动脉根部病变患者,VSRR可作为生物Bentall的替代选择,尤其关注远期心脏生存和避免抗凝相关并发症。
- VSRR可能降低感染性心内膜炎、永久起搏器植入和心衰发作风险,但需个体化评估瓣膜保留可行性。
- 生物Bentall组神经系统并发症和起搏器植入率较高,围术期需加强相关监测。
局限性
- 回顾性研究设计,存在选择偏倚可能。
- 即使采用IPTW,未测量混杂因素可能影响结果。
- 样本量有限,尤其VSRR组仅82例。
- 单一生涯中心或多中心数据可能限制普适性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Valve-sparing root replacement (VSRR) with the David technique is an established therapy for aortic root pathology in young patients. This study evaluated short- and long-term outcomes between VSRR and aortic root replacement (ARR) with a biological-valved conduit in sexagenarians. METHODS: A multicenter retrospective review from 2002 to 2022 identified 299 sexagenarians undergoing aortic root surgery, among whom 82 (27.4%) underwent VSRR and 217 (72.6%) underwent bio-Bentall. Inverse probability of treatment weighting (IPTW) was applied to balance clinical variables. Median follow-up was 15 years (interquartile range, 12-18 years). Study end points were in-hospital mortality, long-term survival, freedom from reintervention, and recurrence of at least moderate aortic regurgitation (AR). RESULTS: There were no major differences in baseline characteristics. The incidence of bicuspid valves (VSRR, 4.9%; ARR, 19%), severe AR (42% vs 51%), type A aortic dissection (1.2% vs 6.9%), and reoperation (4% vs 23%) were higher in ARR. After IPTW, there was no difference in in-hospital mortality (VSRR, 1.2%; ARR, 4.6%; P = .3). The incidence of neurologic complications (P = .003) and permanent pacemaker implantation (P = .022) were significantly higher in the bio-Bentall group. After IPTW, 10-year survival did not differ between VSRR (87%) and ARR (80%; P = .176). However, cardiac survival was significantly higher in VSRR patients (98% vs 92%, P = .018), with deaths mainly due to infective endocarditis and end-stage heart failure. No difference was reported in reoperation/recurrence of at least moderate AR among the groups at 10 years, with only 1 patient undergoing reintervention after bio-Bentall (P = .117). CONCLUSIONS: David and bio-Bentall procedures have low in-hospital mortality and good long-term survival in sexagenarians. VSRR is associated with improved long-term cardiac survival, lower rates of infective endocarditis, permanent pacemaker implantation, and heart failure episodes, with similar rates of reintervention/recurrence of moderate AR.
引用
- Sala A, Di Mauro M, Zancanaro E, et al. Valve-Sparing vs Bio-Bentall Aortic Root Replacement in Patients Aged 60 to 75 Years: Survival, Reintervention, and Aortic Regurgitation. Ann Thorac Surg. 2025. PMID: 39828076. doi:10.1016/j.athoracsur.2024.12.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。